SCHEMBL24525797

SCHEMBL24525797

CCCC1CC/C(C)=C\CCN1C

nearest known ligand 0.35

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.32
▸ ADRA2A P08913 1/20 0.31
▸ MEN1 O00255 1/20 0.30
▸ CNR2 P34972 1/20 0.30
▸ KMT2A Q03164 1/20 0.30
▸ PPARA Q07869 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17830004 0.71 — —
SCHEMBL17830005 0.71 — —
SCHEMBL24370195 0.71 — —
SCHEMBL60463 0.68 — —
SCHEMBL11921 0.68 — —
SCHEMBL11926 0.68 — —
SCHEMBL1760663 0.66 CYP1A2 (0.64) CYP1A2ADRA2A
Bromide SCHEMBL27865865 0.66 CYP1A2 (0.53) CYP1A2ADRA2A
SCHEMBL3476022 0.66 CYP1A2 (0.64) CYP1A2ADRA2A
SCHEMBL25008975 0.66 HTR2A (0.41) ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022133215-A1 CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS PRELUDE THERAPEUTICS INCORPORATED (US) 2022-06-23 — — WO disclosed
Send feedback